Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases
European Journal of Cancer · 2024
DOI: 10.1016/j.ejca.2024.114101 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Ines Pires da Silva und 19 weiteren Autor:innen. Beteiligte Einrichtung: Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine & Health, The University of Sydney, NSW, Australia; C…. Hauptthemen laut MEDLINE: Melanoma, Liver Neoplasms, CTLA-4 Antigen, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Tour de Cure Ltd, NHMRC.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine & Health, The University of Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, NSW, Australia; Crown…
- Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.
- Department of Dermatology, University Hospital Essen, and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany.
- The Christie NHS Foundation Trust, Manchester, UK.
- Vanderbilt University Medical Center, Nashville, TN, United States.
- Department of Medical Oncology, IDIBAPS, Hospital Clínic, Barcelona, Spain.
Förderung
- Tour de Cure Ltd
- NHMRC
Zitieren
APA
Pires da Silva, I., Li, I., Ugurel, S., Serra-Bellver, P., Andhale, A., Burnette, H., Aya, F., Conway, J. W., Braden, J., Carlino, M. S., Menzies, A. M., Weichenthal, M., Mohr, P., Gutzmer, R., Arance, A. M., Johnson, D. B., Lorigan, P., Schadendorf, D., Lo, S. N., & Long, G. V. (2024). Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114101
Vancouver
Pires da Silva I, Li I, Ugurel S, Serra-Bellver P, Andhale A, Burnette H, et al. Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.114101
BibTeX
@article{PiresdaSilva2024,
author = {Pires da Silva, Ines and Li, Isabel and Ugurel, Selma and Serra-Bellver, Patricio and Andhale, Avanti and Burnette, Hannah and Aya, Francisco and Conway, Jordan W and Braden, Jorja and Carlino, Matteo S and Menzies, Alexander M and Weichenthal, Michael and Mohr, Peter and Gutzmer, Ralf and Arance, Ana M and Johnson, Douglas B and Lorigan, Paul and Schadendorf, Dirk and Lo, Serigne N and Long, Georgina V},
title = {Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases},
journal = {European Journal of Cancer},
year = {2024},
doi = {10.1016/j.ejca.2024.114101}
}
EUVIMED